Havencrest Healthcare

Havencrest is a Dallas-based healthcare-focused private equity investment firm, not a drug-development biotech or pharmaceutical operating company. The firm invests in lower middle-market, founder-owned healthcare businesses and seeks to build market-leading platforms through operational improvement and strategic M&A. Its portfolio has included healthcare services, home care, behavioral health, hospice and palliative care, clinical trial site networks, and healthcare staffing businesses. Havencrest was founded by Christopher W. Kersey and has raised dedicated healthcare funds including Havencrest Healthcare Partners II, a $356 million fund closed in 2022. For a biotech analyst, the key point is that Havencrest is healthcare-related as an investor and consolidator, but it does not appear to run a therapeutic R&D pipeline of drugs or biologics itself.